EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials

Martina D'Angelo, Luca Steardo iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25073603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Martina D'Angelo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatry Unit, Department of Health Sciences, University of Catanzaro Magna Graecia, 88100 Catanzaro, Italy. Hauptthemen laut MEDLINE: Cannabinoids, Cannabidiol, Sleep Wake Disorders. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endogenous cannabinoid system (ECS) plays a critical role in the regulation of various physiological functions, including sleep, mood, and neuroinflammation. Phytocannabinoids such as Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinomimimetics, and some N-acylethanolamides, particularly palmitoyethanolamide, have emerged as potential therapeutic agents for the management of sleep disorders. THC, the psychoactive component of cannabis, may initially promote sleep, but, in the long term, alters sleep architecture, while CBD shows promise in improving sleep quality without psychoactive effects. Clinical studies suggest that CBD modulates endocannabinoid signaling through several receptor sites, offering a multifaceted approach to sleep regulation. Similarly, palmitoylethanolamide (PEA), in addition to interacting with the endocannabinoid system, acts as an agonist on peroxisome proliferator-activated receptors (PPARs). The favorable safety profile of CBD and PEA and the potential for long-term use make them an attractive alternative to conventional pharmacotherapy. The integration of the latter two compounds into comprehensive treatment strategies, together with cognitive–behavioral therapy for insomnia (CBT-I), represents a holistic approach to address the multifactorial nature of sleep disorders. Further research is needed to establish the optimal dosage, safety, and efficacy in different patient populations, but the therapeutic potential of CBD and PEA offers hope for improved sleep quality and general well-being.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabinoidsCannabidiolSleep Wake DisordersHumansEndocannabinoidsSleep

Stichwörter der Autor:innen

cannabidiolendogenous cannabinoid systempalmitoylethanolamidesleep

Substanzen

CannabinoidsEndocannabinoidsCannabidiol

Autor:innen und Institutionen

  • Psychiatry Unit, Department of Health Sciences, University of Catanzaro Magna Graecia, 88100 Catanzaro, Italy.

ORCID-Profile: Luca Steardo

Zitieren

APA

D'Angelo, M., & Steardo, L. (2024). Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073603

Vancouver

D'Angelo M, Steardo L. Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073603

BibTeX
@article{DAngelo2024,
  author = {D'Angelo, Martina and Steardo, Luca},
  title = {Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25073603}
}
Kostenlos starten →